INNOVATIVE RESEARCH
The institute provides a world-class interdisciplinary training environment for the preparation of technically skilled students who are capable of filling the diverse workforce needs in biomedical sciences. With key assets including centers for the study of inflammation, immunity and infection, microbial pathogenesis, oncology, molecular and cellular medicine and diagnostics and therapeutics the unit delivers both academic and research value to the field.
We’re launching a bachelor’s degree program. The program prepares students for employment in the biomedical industry or advanced degrees in science, business or law. Learn More
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute of Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the Institute each year, and the university is planning even more expansion.
More
Top Stories
Biomedical Sciences Researcher Gets $3.26 Million Grant To Develop Universal Flu Vaccine
Influenza remains a major public health risk, and Dr. Baozhong Wang, associate professor in Georgia State University’s Institute for Biomedical Sciences, has received a five-year, $3.26 million federal grant to combat this threat by developing a universal vaccine that offers more protection against influenza than seasonal vaccines.read more ❯
Biomedical Sciences Researchers Find Fecal Marker Could Help Diagnose Early Signs of Chronic Gut Conditions
Small molecules found in fecal matter could provide clues to the early inflammation found in chronic gut conditions, such as inflammatory bowel disease (IBD), and serve as new biomarkers for diagnosis, according to a study led by the Institute for Biomedical Sciences at Georgia State University.read more ❯
Researcher Identifies Adjuvant That Prevents Vaccine-Enhanced Respiratory Disease In RSV, Study Finds
A unique adjuvant, a substance that enhances the body’s immune response to toxins and foreign matter, can prevent vaccine-enhanced respiratory disease, a sickness that has posed a major hurdle in vaccine development for respiratory syncytial virus (RSV), according to a study led by the Institute for Biomedical Sciences at Georgia State University.read more ❯